Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience (Q30424687)

11 August 2017

Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience (English)

1 reference

autosomal dominant polycystic kidney disease

11 August 2017

0 references

autosomal dominant polycystic kidney

1 reference

7

Shigeo Horie

1 reference

11 August 2017

Eiji Higashihara

1

1 reference

11 August 2017

Vicente E Torres

2

1 reference

11 August 2017

Arlene B Chapman

3

1 reference

11 August 2017

Jared J Grantham

4

1 reference

11 August 2017

Kyongtae Bae

5

1 reference

11 August 2017

Terry J Watnick

6

1 reference

11 August 2017

Kikuo Nutahara

8

1 reference

11 August 2017

John Ouyang

9

1 reference

11 August 2017

Holly B Krasa

10

1 reference

11 August 2017

Frank S Czerwiec

11

1 reference

11 August 2017

TEMPOFormula and 156-05-002 Study Investigators

12

1 reference

11 August 2017

8 September 2011

1 reference

Clinical Journal of the American Society of Nephrology

11 August 2017

1 reference

11 August 2017

6

1 reference

11 August 2017

10

1 reference

11 August 2017

2499-2507

1 reference

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Water prescription in autosomal dominant polycystic kidney disease: a pilot study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Vasopressin in chronic kidney disease: an elephant in the room?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Clinical practice. Autosomal dominant polycystic kidney disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Surrogate end points for clinical trials of kidney disease progression

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Pain management in polycystic kidney disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359559

Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group

26 November 2018

1 reference

12 December 2020

Autosomal dominant polycystic kidney disease

1 reference

12 December 2020

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study

1 reference

12 December 2020

Volume progression in polycystic kidney disease

1 reference

12 December 2020

Autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.03530411

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

21903984

1 reference